United States· US:70518-0174_47e3f082-89ce-b50f-e063-6294a90ad1a6
Lisinopril and Hydrochlorothiazide
A thiazides, plain product containing lisinopril and hydrochlorothiazide, registered in United States by REMEDYREPACK INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Lisinopril and Hydrochlorothiazide
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- C03AA
- ATC class
- Thiazides, plain
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 4
- ndc11705180174030 TABLET in 1 BOTTLE, PLASTIC (70518-0174-0)
- ndc11705180174190 TABLET in 1 BOTTLE, PLASTIC (70518-0174-1)
- ndc117051801742100 TABLET in 1 BOTTLE, PLASTIC (70518-0174-2)
- ndc11705180174330 TABLET in 1 BLISTER PACK (70518-0174-3)
Regulatory notes
Same class
Other records under C03AA
Thiazides, plain, as other registers publish it.
- United StatesIrbesartan and HydrochlorothiazideBryant Ranch Prepack
- United StatesIrbesartan and HydrochlorothiazideSolco Healthcare US, LLC
- United StatesIrbesartan and HydrochlorothiazideSolco Healthcare US, LLC
- United StatesLisinopril and HydrochlorothiazideREMEDYREPACK INC.
- United StatesLisinopril and HydrochlorothiazideST. MARY'S MEDICAL PARK PHARMACY
- United StatesLisinopril and HydrochlorothiazideREMEDYREPACK INC.
- United StatesLosartan Potassium and HydrochlorothiazideST. MARY'S MEDICAL PARK PHARMACY
- United StatesTriamterene and HydrochlorothiazideSt Mary's Medical Park Pharmacy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2e5d93d-465e-40bc-92bb-f3a233d8e29f GET /v1/drugs/a2e5d93d-465e-40bc-92bb-f3a233d8e29f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "0J48LPH2TH",
"rxcui": "5487",
"inchikey": "JZUFKLXOESDKRF-UHFFFAOYSA-N",
"display_name": "HYDROCHLOROTHIAZIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"ab561d21-7466-4d8b-8d06-291c1d4d82ff": {
"match": "brand_token",
"title": "LISINOPRIL TABLET [PREFERRED PHARMACEUTICALS INC.]",
"spl_version": "9",
"published_date": "2026-06-01"
}
},
"productid": "70518-0174_47e3f082-89ce-b50f-e063-6294a90ad1a6",
"productndc": "70518-0174",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "077912",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "12.5MG;10MG",
"product_no": "001",
"approval_date": "Sep 27, 2006"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "12.5MG;20MG",
"product_no": "002",
"approval_date": "Sep 27, 2006"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "25MG;20MG",
"product_no": "003",
"approval_date": "Sep 27, 2006"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "HYDROCHLOROTHIAZIDE; LISINOPRIL",
"shortage_reason": "Hydrochlorothiazide; Quinapril Hydrochloride Tablet",
"shortage_status": "current",
"proprietary_name": "Lisinopril and Hydrochlorothiazide",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA077912",
"marketing_category": "ANDA",
"nonproprietary_name": "Lisinopril and Hydrochlorothiazide",
"start_marketing_date": "20170123",
"active_numerator_strength": "25; 20"
}See everything about lisinopril and hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.